Sunny Gupta, MD
Orthopaedic Surgery · Monroe, LANPI 1679934459
Payments from drug & device makers
What this record shows
This record is dominated by grants: $30,000 of the $40,122 with a category attached, or 74.8%. Arthrex accounts for 88.3% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $20,000 and has fallen 99.9% since, to $21 in 2025. Among orthopaedic surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $581.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$35K
- Stryker$3K
- Midsouth Orthopedics Inc.$1K
- Smith+Nephew$99
- Johnson & Johnson$72
- Bioventus LLC$52
- plus $120 from 5 others
What the payments were for
- Grants$30,00075%
- Travel & lodging$3,2568%
- Food & beverage$1,5054%
- Education$5,36213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 27 | $35,426 |
| Stryker | 29 | $3,154 |
| Midsouth Orthopedics Inc. | 1 | $1,200 |
| Smith+Nephew | 2 | $99 |
| Johnson & Johnson | 1 | $72 |
| Bioventus LLC | 3 | $52 |
| KCI USA, Inc. | 1 | $32 |
| Amgen | 2 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Vertex | 1 | $21 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$40,122 in reported general payments places this provider in the 90th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $188 |
| Ondansetron Hcl | 24 | $117 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Monroe
- William EnsmingerMonroe$28K
- Christopher HarrodBaton Rouge$3M
- Vinod DasaKenner$1.9M
- Pierce NunleyShreveport$1.8M
- Jorge IsazaBaton Rouge$1.2M
- Neil MakiThibodaux$620K
- Robert ZuraNew Orleans$597K
- Kevin McCarthyBaton Rouge$594K
- Timmothy RandellAlexandria$498K
- Fernando SanchezNew Orleans$484K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.